Sun, Sep 21, 2014, 2:23 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.


  • fighterpilot fighterpilot Feb 1, 2013 9:13 PM Flag

    Better vision patients


    with better results will be huge. Easy to compare, easy confirmation, easy to predict higher share price.

    The next coffee and donut in the VIP section of the ACTC waiting room is on me.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Let's hope so. I can only hope that the plan, if it goes well, is to use the data to further expedite the trials as well. If we can continue to prove safety and also great efficacy with better vision patients, it wouldn't make sense to take a step "down" to worse vision patients.

      The fact that they allowed the patients to be treated at once rather than one at a time is also re-assuring. It shows that the FDA must have a lot of confidence when it comes to safety. The folks with better vision have more to lose.

      I suspect we have a lot to look forward to as these patients are treated.

0.08150.0000(0.00%)Aug 27 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.